Las Vegas, NV -- (SBWIRE) -- 01/14/2014 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: Joe's Jeans Inc (NASDAQ:JOEZ), Staples, Inc. (NASDAQ:SPLS), Molycorp Inc (NYSE:MCP), AEterna Zentaris Inc. (USA) (NASDAQ:AEZS).
Joe's Jeans Inc (NASDAQ:JOEZ) ended its recent business day with the advanced of 12.17% and closed at the price of $1.29 after opening at $10.14. The stock traded during its last trading session with the total volume of 4.09 million shares, as compared to its average volume of 379,475.00 shares. Joe’s Jeans Inc. engages in the design, development, production, and marketing of apparel products under the Joe’s brand name in the United States. It operates in two segments, wholesale and Retail.
Will JOEZ Continue To Move Higher? Find out via this report
Staples, Inc. (NASDAQ:SPLS) remained among the day bearish -3.14% and traded with volume of 8.35 million shares in the last session, as compared to average volume of 8.01 million shares. In comparison with 52 week range of $11.70 - $17.30, it faced lowest price of $14.40 during the last trading session whereas its day highest price was $15.02. The company’s total market capitalization is $9.48 billion, along with 653.68 million shares outstanding. Staples, Inc., together with its subsidiaries, operates as an office products company. It operates in three segments: North American Stores & Online, North American Commercial, and International Operations.
Why Should Investors Buy SPLS After the Recent Fall? Just Go Here and Find Out
Molycorp Inc (NYSE:MCP) showed 7.66 million shares in volume during the last trading session, while the average trading volume remained 8.30 million shares. The stock kicked off its trading session at $5.46 and closed at $5.32 after dropped -1.85%. Molycorp, Inc. produces and sells rare earth and rare metal materials in the United States and internationally.
Will MCP Get Buyers Even After The Recent Rally? Find Out Here
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) stock traded during its last trading session with the total traded volume of 3.79 million shares versus its average volume of 2.58 million shares. The company opened its trade at the price of $1.29 and its closing price was $1.24 after fell -0.80% for the day. Aeterna Zentaris Inc. (NASDAQ: AEZS) is a specialty biopharmaceutical company engaged in developing novel treatments in oncology and endocrinology. The Company's pipeline encompasses compounds from drug discovery to regulatory approval. Its lead oncology program is an ongoing Phase 3 trial in endometrial cancer with zoptarelin doxorubicin (formerly AEZS-108). Its lead endocrinology product is macimorelin acetate (formerly AEZS-130) for which an NDA has been submitted to the FDA, seeking approval for the marketing and sales of macimorelin acetate as the first orally-administered product that induces growth hormone release to evaluate Adult Growth Hormone Deficiency (AGHD). Its pipeline also encompasses other earlier-stage programs in both oncology and endocrinology.
Has AEZS Found The Bottom and Ready To Move Up? Find Out Here
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)